common glp 1 drugs Market Overview: GLP-1 Agonists and the Obesity Market | Blog What are experts learning about

Substance use comorbidity in bipolar disorder: a qualitative review of treatment strategies and outcomes

doi: 10.2337/diab.42.5.658 95 ReedJBainSKanamarlapudiV

A Novel CCK-8/GLP-1 hybrid peptide exhibiting prominent insulinotropic, glucose-lowering, and satiety actions with significant therapeutic potential in high-fat-fed mice

10.1016/j.jhepr.2024.101250 41 GuptaN

Although tirzepatide did not meet the criterion for superiority to dulaglutide with respect to the primary endpoint, a prespecified subgroup analysis suggested a possible lower incidence of death from any cause and of death from noncardiovascular causes in the tirzepatide group than in the dulaglutide group